Intra-CeA R121919 blocked both excessive palatable food intake and anxiety-like behavior in Chow/Palatable rats, without affecting chow hypophagia. Conversely, intra-BlA R121919 reduced the chow hypophagia in Chow/Palatable rats, without affecting excessive palatable food intake or anxiety-like behavior. Intra-BNST treatment had no effect. The treatments did not modify the behavior of Chow/Chow rats. Immunohistochemistry revealed an increased number of CRF-positive cells in CeA-but not in BlA Volasertib mouse or BNST-of Chow/Palatable

rats, during both withdrawal and renewed access to the palatable diet, compared with controls. These results provide functional evidence that the CRF-CRF1 receptor system in CeA and BlA has a differential role in mediating maladaptive behaviors resulting from palatable diet cycling. Neuropsychopharmacology (2013)”
“Alpha interferon (IFN-alpha)-based therapy can effectively treat chronic hepatitis B virus (HBV) infection, which causes life-threatening complications. Responses to IFN-alpha therapy vary greatly in chronic hepatitis B (CHB) patients, but underlying mechanisms are almost unknown. In this study, we found that IFN-alpha treatment induced a marked decrease of microRNA-122 (miR-122) expression in hepatocytes. We next showed that IFN-alpha-induced miR-122 downregulation was only partly due to transcriptional

suppression. One IFN-stimulated gene (ISG), NT5C3, which was identified as a miR-122 target, C646 order efficiently inhibited miR-122 by binding and sequestering nearly miR-122 with its mRNA 3′-untranslated region (3′-UTR), indicating that this ISG is involved in IFN-alpha-mediated miR-122 suppression. Notably, the inhibitory effect of IFN-alpha on miR-122 was completely abolished by blocking IFN-alpha-induced upregulation of NT5C3 mRNA expression by RNA interference (RNAi). Meanwhile, we observed that miR-122 dramatically inhibited HBV expression and replication. Finally, we showed that IFN-alpha-mediated HBV-inhibitory effects could be enhanced significantly

by blocking IFN-alpha-induced downregulation of miR-122. We therefore concluded that IFN-alpha-induced inhibition of miR-122 may negatively affect the anti-HBV function of IFN-alpha. These data provide valuable insights for a better understanding of the antiviral mechanism of IFN-alpha and raise further potential interest in enhancing its anti-HBV efficacy.”
“Clinical proteomics faces extremely complex and variable data. Here, we present an updated version of the Griss Proteomics Database Engine (GPDE): A free biological proteomic database specifically designed for clinical proteomics and biomarker discovery (http://gpde.sourceforge.net). It combines experiments based on investigated cell types thereby supporting customizable biological meta-analyses. Through the new features described here, the GPDE now became a powerful yet easy-to-use tool to support the fast identification and reliable evaluation of biomarker candidates.